BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10644272)

  • 1. Hepatic failure in a patient taking rosiglitazone.
    Forman LM; Simmons DA; Diamond RH
    Ann Intern Med; 2000 Jan; 132(2):118-21. PubMed ID: 10644272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
    Lebovitz HE; Kreider M; Freed MI
    Diabetes Care; 2002 May; 25(5):815-21. PubMed ID: 11978674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone and hepatic failure.
    Freid J; Everitt D; Boscia J
    Ann Intern Med; 2000 Jan; 132(2):164. PubMed ID: 10644281
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular injury in a patient receiving rosiglitazone. A case report.
    Al-Salman J; Arjomand H; Kemp DG; Mittal M
    Ann Intern Med; 2000 Jan; 132(2):121-4. PubMed ID: 10644273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
    Bonkovsky HL; Azar R; Bird S; Szabo G; Banner B
    Dig Dis Sci; 2002 Jul; 47(7):1632-7. PubMed ID: 12141828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone-induced hepatic failure leading to liver transplantation. A case report.
    Neuschwander-Tetri BA; Isley WL; Oki JC; Ramrakhiani S; Quiason SG; Phillips NJ; Brunt EM
    Ann Intern Med; 1998 Jul; 129(1):38-41. PubMed ID: 9652998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones and liver toxicity.
    Scheen AJ
    Diabetes Metab; 2001 Jun; 27(3):305-13. PubMed ID: 11431595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group.
    Murphy EJ; Davern TJ; Shakil AO; Shick L; Masharani U; Chow H; Freise C; Lee WM; Bass NM
    Dig Dis Sci; 2000 Mar; 45(3):549-53. PubMed ID: 10749332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case series of liver failure associated with rosiglitazone and pioglitazone.
    Floyd JS; Barbehenn E; Lurie P; Wolfe SM
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
    Kohlroser J; Mathai J; Reichheld J; Banner BF; Bonkovsky HL
    Am J Gastroenterol; 2000 Jan; 95(1):272-6. PubMed ID: 10638596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset rosiglitazone-associated acute liver failure in a patient with Hodgkin's lymphoma.
    El-Naggar MH; Helmy A; Moawad M; Al-Omary M; Al-Kadhi Y; Habib B
    Ann Pharmacother; 2008 May; 42(5):713-8. PubMed ID: 18397974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

  • 14. Pioglitazone-associated fulminant hepatic failure.
    Chase MP; Yarze JC
    Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
    [No Abstract]   [Full Text] [Related]  

  • 15. Second-generation thiazolidinediones and hepatotoxicity.
    Marcy TR; Britton ML; Blevins SM
    Ann Pharmacother; 2004 Sep; 38(9):1419-23. PubMed ID: 15266041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone-associated hepatic failure.
    Booth AM; Caldwell SH; Iezzoni JC
    Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
    [No Abstract]   [Full Text] [Related]  

  • 17. Lessons from the glitazones: a story of drug development.
    Gale EA
    Lancet; 2001 Jun; 357(9271):1870-5. PubMed ID: 11410214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
    May LD; Lefkowitch JH; Kram MT; Rubin DE
    Ann Intern Med; 2002 Mar; 136(6):449-52. PubMed ID: 11900497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone.
    Goldstein BJ
    Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Kermani A; Garg A
    Mayo Clin Proc; 2003 Sep; 78(9):1088-91. PubMed ID: 12962163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.